search
  • Country
    Clear
  • Thematic
    Clear
  • Type
  • Compatibility Level
  • Jurisdiction
2,479 Data sources

  • NL
  • IT
  • BE
  • GR
  • Thematic: No

  • University of Ioannina Libraries through the use of the I.R. "OLYMPIAS" collect, store, index, maintain and distribute the research work of the members of its academic community in digital form. It is an Institutional Repository for dissertations, postgraduate theses and doctoral dissertations, as well as journal publications and conference presentations and proceedings of the academic community members. "OLYMPIAS" also includes digitized material (books and magazines) concerning the Epirus Region which is a geographic and administrative region in northwestern Greece.

    more_vert
  • more_vert
  • more_vert
  • Open Access repository of INFN publications and data, to be eventually extended to other organisations. The interface is in English.

    more_vert
  • The Database of Protein Disorder (DisProt) is a curated database that provides information about intrinsically disordered proteins that lack fixed 3D structure in their putatively native states, either in their entirety or in part. Disordered regions are manually curated from literature. DisProt annotations cover both structural and functional aspects of disorder detected by specific experimental methods.

    more_vert
  • This site provides access to the research output of the institution. Some items are not available as full text. The interface in French and English

    more_vert
  • University of Groningen institutional repository

    more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • This site provides access to the research output of the institution. The interface is available in Italian and English. Some content is not available as full-text.

    more_vert
  • chevron_left
  • 1
  • 2
  • 3
  • 4
  • 5
  • chevron_right
2,479 Data sources
  • University of Ioannina Libraries through the use of the I.R. "OLYMPIAS" collect, store, index, maintain and distribute the research work of the members of its academic community in digital form. It is an Institutional Repository for dissertations, postgraduate theses and doctoral dissertations, as well as journal publications and conference presentations and proceedings of the academic community members. "OLYMPIAS" also includes digitized material (books and magazines) concerning the Epirus Region which is a geographic and administrative region in northwestern Greece.

    more_vert
  • more_vert
  • more_vert
  • Open Access repository of INFN publications and data, to be eventually extended to other organisations. The interface is in English.

    more_vert
  • The Database of Protein Disorder (DisProt) is a curated database that provides information about intrinsically disordered proteins that lack fixed 3D structure in their putatively native states, either in their entirety or in part. Disordered regions are manually curated from literature. DisProt annotations cover both structural and functional aspects of disorder detected by specific experimental methods.

    more_vert
  • This site provides access to the research output of the institution. Some items are not available as full text. The interface in French and English

    more_vert
  • University of Groningen institutional repository

    more_vert
  • Nearly 60% of patients undergoing cancer treatment are estimated to have had at least one potential drug-drug interaction; for patients receiving oral anticancer therapy, up to 50% have been reported to experience a potential drug-drug interaction, with 16% experiencing a major event. Drug-drug interactions are therefore a significant issue for cancer patients and the health care professionals who treat them. Combining the internationally recognised drug-drug interactions expertise of the University of Liverpool (UK) with the clinical pharmacology in oncology and haemotology expertise of Radboud University, Nijmegen (the Netherlands), this site was established in 2017 in response to the need for improved management of DDIs with anti-cancer agents.

    more_vert
  • more_vert
  • This site provides access to the research output of the institution. The interface is available in Italian and English. Some content is not available as full-text.

    more_vert
  • chevron_left
  • 1
  • 2
  • 3
  • 4
  • 5
  • chevron_right